Clin2
NCT07262060Possibly a fitRecruiting

Preventing kidney problems in preterm babies with caffeine

Kidney InjuryPre-Term

Treatments studied

Part of Kidney & urinary, Women’s health & pregnancy clinical trials.

This study tests whether giving caffeine to very premature babies can help protect their kidneys as they grow. We will use a special light monitor on the skin to check blood flow to the brain and kidneys.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
114 people
Ages
12 hours to 4 days
Study type
Interventional

Who can take part

  • Your baby was born extremely early, between 23 and 29 weeks and 6 days.
  • Your baby is already getting caffeine (a medicine that helps with breathing).
  • Your baby has a small tube already in place for giving medicine or drawing blood, like an umbilical line, PICC line, or arterial line.
  • Your baby does not have a major birth defect of the brain, heart, lungs, or kidneys (except minor kidney widening).
  • Your baby does not have any known genetic or chromosome condition.
  • A parent or guardian who is at least 18 years old can give permission in English or Spanish.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06781476Recruiting
Urine markers in very premature babies

This study will collect urine from very premature or very low birth weight babies to look for patterns in natural chemicals (biomarkers). The goal is to find early clues about their health that could lead to better care.

Bologna, Bologna
NCT07216365Recruiting· Phase 2
Caffeine dosing study for very premature babies

This study is testing different doses of caffeine to improve oxygen levels in extremely low birth weight babies born before 28 weeks. We want to see which dose works best to help their breathing.

Rochester, New York
NCT07456670Not yet recruiting· Phase 2
Caffeine for premature babies on breathing support

This study tests whether giving caffeine to premature babies (born at 28 to 34 weeks) who need breathing help can reduce the time they need respiratory support. Caffeine is a common medicine that helps stimulate breathing in premature infants.

Kingston, Ontario
NCT07274969Not yet recruiting
Caffeine therapy and heart stability in premature babies

This study looks at whether giving caffeine to premature babies helps keep their hearts stable. It may help parents understand if caffeine treatment is safe for their baby's heart.

NCT06972849Not yet recruiting
Caffeine for premature babies' breathing and health

This trial tests whether giving caffeine citrate early to very premature babies (born before 32 weeks) improves their breathing and long-term health. It aims to find the best way to use this common medicine to help your baby grow and develop.

NCT06518603Recruiting· Phase 4
Caffeine for preventing apnea in preterm babies in Zambia

This trial tests whether giving caffeine citrate can help prevent breathing pauses (apnea) in preterm babies who are ready to stop their current caffeine treatment. It aims to see if a short course of caffeine can keep babies stable after they come off oxygen and are eating well.

Lusaka, Lusaka Province

Hear when a new Kidney Injury trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.